• Salesforce secured a $1.6b, multi year contract with the U.S. Department of Veterans Affairs to modernize Veteran care and services.
• The VA will use Salesforce’s AI powered Missionforce platform to support healthcare, benefits, and administrative workflows across its network.
• This agreement expands Salesforce’s role in U.S. federal workloads that rely on AI, data integration, and collaboration tools.

For investors tracking NYSE:CRM, this VA contract lands at a time when the stock has faced sustained pressure. Salesforce shares recently closed at $156.93, with the price down 38.1% year to date and 40.9% over the past year. Over a 5 year span, the stock is down 34.6%, underlining how sentiment around Salesforce has been challenged despite its large enterprise presence.

The size and profile of this multi year VA deal highlight how Salesforce is being selected for high stakes government workloads that depend on reliable AI and data platforms. Readers may want to watch how effectively the company executes on this contract and whether similar large scale public sector opportunities emerge, as that could influence how the market views the role of AI driven platforms in complex healthcare and government systems.

Stay updated on the most important news stories for Salesforce by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Salesforce.

Quick Assessment

• ✅ Price vs Analyst Target: Salesforce trades at US$156.93 versus an analyst consensus target of US$241.72, around 35% below that level.
• ✅ Simply Wall St Valuation: The stock is assessed as trading 55.8% below estimated fair value, pointing to an undervalued label in this framework.
• ✅ Recent Momentum: A 30 day return of 2.3% shows recent gains despite longer term pressure on the share price.

There's only one way to know the right time to buy, sell or hold Salesforce. Head to Simply Wall St's company report for the latest analysis of Salesforce's Fair Value.

Key Considerations

• 📊 The US$1.6b VA contract signals that Salesforce’s AI powered Missionforce platform is being chosen for complex, large scale government workloads.
• 📊 Watch how efficiently Salesforce converts this contract into revenue and margins, and whether it leads to additional public sector or healthcare wins.
• ⚠️ Simply Wall St flags high debt as a risk, so investors may want to see that new contracts support balance sheet strength over time.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Salesforce analysis. Alternatively, you can check out the community page for Salesforce to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.